Postoperative Radiation Therapy in Parotid Carcinoma
Indications for Postoperative RT
- The American Society of Clinical Oncology recommends postoperative radiation therapy for patients with adenoid cystic carcinoma, high-grade tumors, and any case with adverse pathologic features including positive margins, perineural invasion, lymph node metastases, or T3-4 disease, with strong evidence supporting its routine use 1, 2
- Postoperative RT is mandatory for tumors with high-grade histology, positive surgical margins, perineural invasion, lymph node metastases, lymphovascular invasion, or T3-4 tumors, according to the American Society of Clinical Oncology 1, 2, 4, 5
Technical Evolution of RT Delivery
- The target volume for postoperative RT should cover the surgical bed and appropriate nodal levels, with a minimum dose of 60 Gy in conventional fractionation, as recommended by the American Society of Clinical Oncology 1, 2
- For perineural invasion, the involved nerve should be covered to the skull base with an elective/intermediate dose (46-54 Gy) to prevent retrograde nerve failure, according to the American Society of Clinical Oncology 1, 2
- Intensity-modulated radiation therapy (IMRT) photon therapy is the current standard, with particle therapy (proton, carbon ion) available but showing no proven superiority over modern photon techniques, as stated by the American Society of Clinical Oncology 1, 4, 6
Definitive RT for Inoperable Disease
- Definitive RT to 70 Gy can achieve clinical complete response in 64.7% of cases and eliminate the need for surgery or reduce facial nerve sacrifice risk in medically or technically inoperable patients, according to the American Society of Clinical Oncology 7
Elective Nodal Irradiation
- Elective neck RT should be offered for cN0 disease with T3-4 tumors or high-grade histology, as the risk of microscopic nodal involvement exceeds 12% for parotid tumors with these features, as recommended by the American Society of Clinical Oncology 4, 7